We've found
184,457
clinical trials
Oncology Clinical Trial
A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Depressive Disorder, Major Clinical Trial
Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 18 Years of Age
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Depressive Disorder, Major Clinical Trial
Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 18 Years of Age
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Overactive Bladder Clinical Trial
Overactive Bladder Treatment Using StimRouter Neuromodulation System: A Prospective Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Optimizing Preventative Adjuvant Linac-Based Radiation: the OPAL Trial - Study of Hypofractionated Partial Breast Irradiation in Women With Early Stage Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
IGA Nephropathy Clinical Trial
Efficacy and Safety of Atacicept in IgA Nephropathy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
IGA Nephropathy Clinical Trial
Efficacy and Safety of Atacicept in IgA Nephropathy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Premature Ejaculation Clinical Trial
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)
Status: Enrolling,
Phase
II
Updated: 3/30/2017
Click here to add this to my saved trials
Premature Ejaculation Clinical Trial
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)
Status: Enrolling,
Phase
II
Updated: 3/30/2017
Click here to add this to my saved trials
Premature Ejaculation Clinical Trial
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)
Status: Enrolling,
Phase
II
Updated: 3/30/2017
Click here to add this to my saved trials
Lennox-Gastaut Syndrome (LGS) Clinical Trial
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Glioblastoma Clinical Trial
Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Glioblastoma Clinical Trial
Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
B-Cell Non Hodgkin Lymphoma Clinical Trial
Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
B-Cell Non Hodgkin Lymphoma Clinical Trial
Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
B-Cell Non Hodgkin Lymphoma Clinical Trial
Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasms Clinical Trial
Study of MK-7684 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasms Clinical Trial
Study of MK-7684 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasms Clinical Trial
Study of MK-7684 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Head and Neck Neoplasms Clinical Trial
Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Head and Neck Neoplasms Clinical Trial
Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Other, Reproductive Clinical Trial
Prediction of Brain Injury in Premature Infants
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis, Relapsing-Remitting Clinical Trial
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis, Relapsing-Remitting Clinical Trial
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Hearing Loss Clinical Trial
Early Auditory Referral in Primary Care
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Clinical Trial
Case Collection Study to Determine the Accuracy, Call Back and Cancer Detection Rates of QT Ultrasound in Breast Imaging
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
184,457
clinical trials
Oncology Clinical Trial
Updated: 12/31/1969
A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Depressive Disorder, Major Clinical Trial
Updated: 12/31/1969
Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 18 Years of Age
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Depressive Disorder, Major Clinical Trial
Updated: 12/31/1969
Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 18 Years of Age
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Overactive Bladder Clinical Trial
Updated: 12/31/1969
Overactive Bladder Treatment Using StimRouter Neuromodulation System: A Prospective Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Optimizing Preventative Adjuvant Linac-Based Radiation: the OPAL Trial - Study of Hypofractionated Partial Breast Irradiation in Women With Early Stage Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
IGA Nephropathy Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Atacicept in IgA Nephropathy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
IGA Nephropathy Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Atacicept in IgA Nephropathy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Premature Ejaculation Clinical Trial
Updated: 3/30/2017
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)
Status: Enrolling,
Phase
II
Updated: 3/30/2017
Click here to add this to my saved trials
Premature Ejaculation Clinical Trial
Updated: 3/30/2017
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)
Status: Enrolling,
Phase
II
Updated: 3/30/2017
Click here to add this to my saved trials
Premature Ejaculation Clinical Trial
Updated: 3/30/2017
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)
Status: Enrolling,
Phase
II
Updated: 3/30/2017
Click here to add this to my saved trials
Lennox-Gastaut Syndrome (LGS) Clinical Trial
Updated: 12/31/1969
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Glioblastoma Clinical Trial
Updated: 12/31/1969
Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Glioblastoma Clinical Trial
Updated: 12/31/1969
Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
B-Cell Non Hodgkin Lymphoma Clinical Trial
Updated: 12/31/1969
Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
B-Cell Non Hodgkin Lymphoma Clinical Trial
Updated: 12/31/1969
Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
B-Cell Non Hodgkin Lymphoma Clinical Trial
Updated: 12/31/1969
Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasms Clinical Trial
Updated: 12/31/1969
Study of MK-7684 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasms Clinical Trial
Updated: 12/31/1969
Study of MK-7684 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasms Clinical Trial
Updated: 12/31/1969
Study of MK-7684 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Head and Neck Neoplasms Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Head and Neck Neoplasms Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
Updated: 12/31/1969
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
Updated: 12/31/1969
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
Updated: 12/31/1969
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
Updated: 12/31/1969
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
Updated: 12/31/1969
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
Updated: 12/31/1969
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
Updated: 12/31/1969
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
Updated: 12/31/1969
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Malignancies Clinical Trial
Updated: 12/31/1969
An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Other, Reproductive Clinical Trial
Updated: 12/31/1969
Prediction of Brain Injury in Premature Infants
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Updated: 12/31/1969
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis, Relapsing-Remitting Clinical Trial
Updated: 12/31/1969
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis, Relapsing-Remitting Clinical Trial
Updated: 12/31/1969
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Hearing Loss Clinical Trial
Updated: 12/31/1969
Early Auditory Referral in Primary Care
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Clinical Trial
Updated: 12/31/1969
Case Collection Study to Determine the Accuracy, Call Back and Cancer Detection Rates of QT Ultrasound in Breast Imaging
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials